We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock
CDMO

Delisted

CDMO was delisted on the 4th of February, 2025.

Back to rankings

66 hedge funds and large institutions have $13.7M invested in Avid Bioservices, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 20 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $12.1M → $13.7M (+$1.55M)

13% less funds holding

Funds holding: 76 → 66 (-10)

40% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 20

77% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 13

Holders
66
Holders Change
-10
Holders Change %
-13.16%
% of All Funds
1.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
12
Reduced
20
Closed
13
Calls
$11K
Puts
–
Net Calls
+$11K
Net Calls Change
-$8K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$427K
2
Deutsche Bank
Deutsche Bank
Germany
+$197K
3
KCM
Kennedy Capital Management
Missouri
+$90.9K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$87.7K
5
Goldman Sachs
Goldman Sachs
New York
+$18K

Top Sellers

Rank Fund Capital Flow
1
PP
Paloma Partners
Connecticut
-$311K
2
LCM
Laurion Capital Management
New York
-$242K
3
Millennium Management
Millennium Management
New York
-$235K
4
CS
Credit Suisse
Switzerland
-$159K
5
PA
Perceptive Advisors
New York
-$76.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
NFA
26
Nationwide Fund Advisors
Ohio
$23K – – –
BFA
27
BlackRock Fund Advisors
California
$18K +$803 +299 +5%
RJFSA
28
Raymond James Financial Services Advisors
Florida
$16K – – –
CAG
29
Crestwood Advisors Group
Massachusetts
$15K – – –
Wolverine Trading
30
Wolverine Trading
Illinois
$14K +$1.26K +468 +11%
PCM
31
Prelude Capital Management
New York
$14K +$10.1K +3,757 +453%
NCCM
32
Nine Chapters Capital Management
New Jersey
$14K +$12.3K +4,586 New
Bank of America
33
Bank of America
North Carolina
$13K -$30K -11,159 -72%
JP Morgan Chase
34
JP Morgan Chase
New York
$13K -$13 -5 -0.1%
LTFS
35
Ladenburg Thalmann Financial Services
Florida
$11K +$3.73K +1,387 +59%
ICOA
36
Investment Centers of America
North Dakota
$11K +$9.59K +3,571 New
PA
37
Perceptive Advisors
New York
$10K -$76.7K -28,571 -89%
SFFS
38
Stonehage Fleming Financial Services
Jersey
$10K – – –
UBS Group
39
UBS Group
Switzerland
$9K -$14.6K -5,444 -65%
RJA
40
Raymond James & Associates
Florida
$9K -$1.15K -428 -13%
SPC
41
Sigma Planning Corp
Michigan
$7K – – –
Stifel Financial
42
Stifel Financial
Missouri
$7K – – –
CA
43
Corrado Advisors
New Jersey
$6K – – –
RT
44
Rockland Trust
Massachusetts
$6K – – –
LPL Financial
45
LPL Financial
California
$6K +$32 +12 +0.6%
IA
46
IFP Advisors
Florida
$5K – – –
DRD
47
Dennis R. Delaney
$4K – – –
Group One Trading
48
Group One Trading
Illinois
$4K – – –
SGS
49
Sterling Global Strategies
California
$4K – – –
WP
50
WealthPLAN Partners
Nebraska
$3.24K -$2.91K -1,085 -50%
1
2
3

CDMO Hedge Fund Activity: Q3 2016 in Review

66 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q3 2016, worth a combined $13.7M — up 13% from $12.1M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of CDMO and 3 opened new positions — a net loss of 10 holders — while 20 trimmed existing stakes and 12 added.

The largest buyer was Renaissance Technologies, adding an estimated $427K. The largest seller was Paloma Partners, exiting entirely with an estimated $311K sold.

  • 66 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q3 2016, down from 76 in Q2 2016.
  • Funds reported $13.7M of Avid Bioservices, Inc. Common Stock stock for Q3 2016, up 13% quarter-over-quarter.
  • 3 funds opened new Avid Bioservices, Inc. Common Stock positions in Q3 2016 and 13 closed out, a net change of -10 holders.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q3 2016 was Renaissance Technologies, an estimated $427K added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q3 2016 was Paloma Partners, an estimated $311K sold.

Based on aggregated 13F filings for Q3 2016.